R&D News | pharmaphorum

News

Freenome raises $254m for cancer tests, and other financings

Our round-up of recent biotech financings is headed by a $254 million private financing for cancer blood test specialist Freenome, with sizeable rounds for Cogent Bioscien

News

Dr Andrew Anzalone, Prime Medicine co-founder and head of platform development

Gene-editing firm Prime Medicine files $140m public offer

Gene-editing biotech Prime Medicine has priced a follow-on public offering, hoping to raise $140 million to advance its pipeline of one-shot therapies for severe genetic d

News

Exercise ‘may be better than drugs for depression’

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study.

News

Grifols eyes first place in US fibrinogen concentrate market

Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatmen

News

Earlybird principal Dr Christoph Massner

VC Earlybird Health raises €173m for healthtech companies

Venture capital group Earlybird has launched its second health fund with €173 million ($185 million) at its disposal to fund companies in the health technology area, more

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

Freenome raises $254m for cancer tests, and other financings

Gene-editing firm Prime Medicine files $140m public offer

Exercise ‘may be better than drugs for depression’

Grifols eyes first place in US fibrinogen concentrate market

VC Earlybird Health raises €173m for healthtech companies

Roche, PathAI team up on AI companion diagnostics

AbbVie invests £120m in UK expansion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks